NuSep Holdings Ltd Completes First Three Trial Production Runs Albumin In Singapore GMP Facility

NuSep Holdings Ltd announced that it has completed three trial production runs of Human Albumin using its pilot production unit in its Singapore, current Good Manufacturing Practise (cGMP) production facility. These trial production runs were completed in a cGMP environment using human plasma kindly provided by the Health Sciences Authority (HSA) of Singapore in association with Defence Medical and Environmental Research Institute. Scientists from the HSA and the Defence Science Organisation (DSO) viewed the 3rd Human Albumin PrIME production run while visiting PrIME Biologics cGMP production facility in Singapore. A report on these 3 trial production runs has been submitted to the HSA.